MentionFox
Home › Who owns › RAPT Therapeutics, Inc.
Owners, funding and legal record

Who owns RAPT Therapeutics, Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in RAPT Therapeutics, Inc.

MentionFox check on RAPT Therapeutics, Inc.: no red flags found in 16 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/who-owns/rapt-therapeutics

  • Note: Layoff plan disclosed Jul 2024 (about 47 employees) (filing)

New since last check: Layoff plan disclosed Jul 2024 (about 47 employees) (filing, first seen 14 November 2026).

Check RAPT Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about RAPT Therapeutics, Inc.?

The most recent 5%+ ownership report on RAPT Therapeutics, Inc. names RTW Investments holding 5.9% (Schedule 13G/A, filed 2026-02-17).

As of November 14, 2026, the most recent 5%+ ownership report on RAPT Therapeutics, Inc. names RTW Investments holding 5.9%. No bankruptcy or receivership appears in its SEC Form 8-K filings. This page cites 16 records in all (Schedule 13G/A, February 17, 2026).

William Rieflin is also named on 1 other Form D filing ↓

Is this your company?

About to sign with, pay or invest in RAPT Therapeutics, Inc.? See the free Snapshot first.

Watch RAPT Therapeutics, Inc.

Free to see. No signup.

Is RAPT Therapeutics, Inc. a real, registered company?

Before you sign or pay

Who are RAPT Therapeutics, Inc.'s owners and officers?

RAPT Therapeutics, Inc.: incorporated in Delaware; business address in South San Francisco, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-05-15).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G/A, 2026-05-15Orbimed Advisors LLC0%
Schedule 13G/A, 2026-05-15Rtw Investments, LP0%
Schedule 13G/A, 2026-02-17Rtw Investments, LP5.9%
Schedule 13G/A, 2026-02-13Deep Track Capital, LP0.4%
Schedule 13G, 2026-02-09Glazer Capital, LLC5.36%
Schedule 13G/A, 2025-11-14Orbimed Advisors LLC6.6%
Schedule 13G/A, 2025-11-14Biotechnology Value Fund L P0%
Schedule 13G/A, 2025-11-14Nantahala Capital Management, LLC3.77%
Schedule 13G/A, 2025-10-30The Vanguard Group4.2%
Schedule 13G, 2025-10-29Forgrowth Iii Pa B.V.7.4%
Schedule 13G, 2025-08-14Nantahala Capital Management, LLC5.75%
Schedule 13G/A, 2025-08-14Redmile Group, LLC9.9%

Questions about who owns RAPT Therapeutics, Inc.

Who owns RAPT Therapeutics, Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of RAPT Therapeutics, Inc.: Redmile Group, LLC (9.9%, Schedule 13G/A, filed 2025-08-14), Forgrowth Iii Pa B.V. (7.4%, Schedule 13G, filed 2025-10-29) and Glazer Capital, LLC (5.36%, Schedule 13G, filed 2026-02-09).

Who are the largest shareholders of RAPT Therapeutics, Inc.?

By the share each holder's latest filing reports, the largest holders of RAPT Therapeutics, Inc. on this page are Redmile Group, LLC (9.9%), Forgrowth Iii Pa B.V. (7.4%) and Glazer Capital, LLC (5.36%).

When did Redmile Group, LLC buy into RAPT Therapeutics, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Redmile Group, LLC on this page is the Schedule 13G/A, filed 2025-08-14, reporting 9.9%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on RAPT Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on RAPT Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on RAPT Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    16 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How much has RAPT Therapeutics, Inc. raised?

FiledSoldOffered
Form D, 2025-01-03$149.98M$149.98M

Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-03-03).

Red flags found

1 exit or restructuring plan on Form 8-K (latest Form 8-K, 2024-07-19).

Keep reading

More on RAPT Therapeutics, Inc. and the records around it.

The people at RAPT Therapeutics, Inc.

RAPT Therapeutics, Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/rapt-therapeutics
Last updated 2026-11-14
Who owns RAPT Therapeutics, Inc.? Owners, funding and legal record. MentionFox, 2026-11-14. https://mentionfox.com/who-owns/rapt-therapeutics